MAUREEN OCONNELL
CIK 1111318 · EVP, CAO & CFO · last filed 2026-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.18M
Companies
6
Total Filings
96
Lifetime Open-Market Net
-$19.81M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTG | Director | 287,655 | $4.51 | $1.30M | $48.5K | 11 | 2026-08-20 |
| TEX | Director | 16,351 | $62.76 | $1.03M | $0 | 2 | 2026-03-09 |
| REV Group, Inc. (REVG) Delisted | Director | 2,105 | $63.90 | $134.5K | $0 | 5 | 2026-02-02 |
| HHS | Director | 25,414 | $4.21 | $107.0K | $0 | 3 | 2020-09-02 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 6 | 2018-02-13 |
| SCHL | EVP, CAO & CFO | 71,771 | $38.32 | $2.75M | -$19.86M | 68 | 2017-09-26 |
Recent Filings · Page 4 of 10
96 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | SCHL | Sell (S) | −8,264 | -$392.1K | EDGAR |
| 2016-12-21 | SCHL | Mixed | — | -$136.4K | EDGAR |
| 2016-12-20 | SCHL | Mixed | −10,025 | -$854.4K | EDGAR |
| 2016-09-26 | SCHL | Tax (F) | −800 | -$31.0K | EDGAR |
| 2016-09-22 | SCHL | Mixed | +3,842 | $150.8K | EDGAR |
| 2016-09-01 | SCHL | Grant (A) | — | $0 | EDGAR |
| 2016-08-04 | SCHL | Tax (F) | −2,406 | -$98.2K | EDGAR |
| 2016-07-11 | SCHL | Mixed | — | -$654.0K | EDGAR |
| 2016-07-07 | SCHL | Mixed | — | -$7.1K | EDGAR |
| 2016-06-06 | Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Grant (A) | +9,800 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.